Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma

Mostrar otras versiones (1)

BACKGROUND: Patients with recurrent glioblastoma have a poor outcome. Data from the phase III registration trial comparing tumour-treating alternating electric fields (TTFields) vs chemotherapy provided a unique opportunity to study dexamethasone effects on patient outcome unencumbered by the confou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, E T, Lok, E, Gautam, S, Swanson, K D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506397/
https://www.ncbi.nlm.nih.gov/pubmed/26125449
http://dx.doi.org/10.1038/bjc.2015.238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506397/
https://www.ncbi.nlm.nih.gov/pubmed/26125449
http://dx.doi.org/10.1038/bjc.2015.238

Ejemplares similares